Literature DB >> 25195884

High-resolution crystal structures of alternate forms of the human CD44 hyaluronan-binding domain reveal a site for protein interaction.

Li-Kai Liu1, Barry Finzel1.   

Abstract

Two new crystal structures of the extracellular hyaluronan-binding domain of human CD44 are described at high resolution. A hexagonal crystal form at 1.60 Å resolution and a monoclinic form at 1.08 Å resolution both have two molecules in the asymmetric unit arranged about a similar noncrystallographic twofold axis of symmetry. These structures are compared with those previously reported at 2.20 Å resolution to show that the fold is quite resistant to structural deformation in different crystal environments. Unexpectedly, a short peptide is found in the monoclinic crystals at a site remote from the known hyaluronan-binding groove. The peptide with a valine at the carboxy-terminus must have co-purified from the bacterial expression host and binds on the opposite side of the domain from the known hyaluronan-binding groove. This opportunistic binding may identify a site of interaction used as CD44 assembles with other proteins to accomplish effective signaling regarding changes to the extracellular environment.

Entities:  

Keywords:  CD44; hyaluronan-binding domain

Mesh:

Substances:

Year:  2014        PMID: 25195884      PMCID: PMC4157411          DOI: 10.1107/S2053230X14015532

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  24 in total

Review 1.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

2.  A6 peptide activates CD44 adhesive activity, induces FAK and MEK phosphorylation, and inhibits the migration and metastasis of CD44-expressing cells.

Authors:  Randolph S Piotrowicz; Bassam B Damaj; Mohamed Hachicha; Francesca Incardona; Stephen B Howell; Malcolm Finlayson
Journal:  Mol Cancer Ther       Date:  2011-09-01       Impact factor: 6.261

3.  A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.

Authors:  Estefanía Ugarte-Berzal; Elvira Bailón; Irene Amigo-Jiménez; Juan Pablo Albar; José A García-Marco; Angeles García-Pardo
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

4.  Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display.

Authors:  Hye-Yeon Park; Kyoung-Jin Lee; Su-Jae Lee; Moon-Young Yoon
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

5.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction.

Authors:  Suneale Banerji; Alan J Wright; Martin Noble; David J Mahoney; Iain D Campbell; Anthony J Day; David G Jackson
Journal:  Nat Struct Mol Biol       Date:  2007-02-11       Impact factor: 15.369

Review 8.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  9 in total

1.  Zona pellucida-binding protein 2 (ZPBP2) and several proteins containing BX7B motifs in human sperm may have hyaluronic acid binding or recognition properties.

Authors:  F Torabi; O A Bogle; J M Estanyol; R Oliva; D Miller
Journal:  Mol Hum Reprod       Date:  2017-12-01       Impact factor: 4.025

2.  Inhibition of Mammalian Glycoprotein YKL-40: IDENTIFICATION OF THE PHYSIOLOGICAL LIGAND.

Authors:  Abhishek A Kognole; Christina M Payne
Journal:  J Biol Chem       Date:  2017-01-04       Impact factor: 5.157

3.  The Cell Surface Receptor CD44: NMR-Based Characterization of Putative Ligands.

Authors:  Carlo Baggio; Elisa Barile; Gianluigi Di Sorbo; Thomas J Kipps; Maurizio Pellecchia
Journal:  ChemMedChem       Date:  2016-05-04       Impact factor: 3.466

Review 4.  Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation.

Authors:  Olgun Guvench
Journal:  Front Immunol       Date:  2015-06-16       Impact factor: 7.561

5.  Atomistic fingerprint of hyaluronan-CD44 binding.

Authors:  Joni Vuorio; Ilpo Vattulainen; Hector Martinez-Seara
Journal:  PLoS Comput Biol       Date:  2017-07-17       Impact factor: 4.475

Review 6.  Dissecting the Dual Nature of Hyaluronan in the Tumor Microenvironment.

Authors:  Muhan Liu; Cornelia Tolg; Eva Turley
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

7.  In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates.

Authors:  Angel J Ruiz-Moreno; Atilio Reyes-Romero; Alexander Dömling; Marco A Velasco-Velázquez
Journal:  Molecules       Date:  2021-03-26       Impact factor: 4.411

8.  Molecular Dynamics Simulation Study on Allosteric Regulation of CD44-Hyaluronan Binding as a Force Sensing Mechanism.

Authors:  Masami Lintuluoto; Yota Horioka; Saki Hongo; Juha Mikael Lintuluoto; Yoshifumi Fukunishi
Journal:  ACS Omega       Date:  2021-03-16

9.  Structural Characterization of the CD44 Stem Region for Standard and Cancer-Associated Isoforms.

Authors:  Kun-Lin Chen; Deng Li; Ting-Xuan Lu; Shu-Wei Chang
Journal:  Int J Mol Sci       Date:  2020-01-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.